← SynDRA
INAVOLISIB
SynDRA canonical compound SYN0040102 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PIK3CA |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PIK3CA INHIBITOR
- PI3-kinase p110-alpha subunit inhibitor
- PI3K inhibitor
- PIK3CG INHIBITOR
Drug classes
- Antineoplastic Agents
- Phosphoinositide-3 Kinase Inhibitors
Cross-references
Synonyms
- GDC-0077
- GDC0077
- RG-6114
- RG6114
- RO-7113755
- RO7113755
- Itovebi
- SGEUNORSOZVTOL-CABZTGNLSA-N
- UNII-L4C1UY2NYH
- L4C1UY2NYH
- GTPL9636
- SCHEMBL18360780
- EX-A2685
- ZINC669678973
- Ro7113755
- CS-6459
- HY-101562
- Propanamide, 2-((2-((4S)-4-(difluoromethyl)-2-oxo-3-oxazolidinyl)-5,6-dihydroimidazo(1,2-d)(1,4)benzoxazepin-9-yl)amino)-, (2S)-
- (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide
- (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxa
- GDC 0077
- RG 6114
- RO 7113755
- RefChem:148062
- PI3K Inhibitor GDC0077
- MFCD31382124
- Inavolisib [USAN]
- X3N
- Itovebi (TN)
- INAVOLISIB [INN]
- Inavolisib (USAN/INN)
- INAVOLISIB [WHO-DD]
- orb1308276
- SCHEMBL29695471
- BDBM295665
- GLXC-24203
- GDC-0077?
- NSC800729
- s8668
Look up INAVOLISIB in the interactive SynDRA portal →